Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells - PubMed (original) (raw)
. 1987 Summer;6(3):215-27.
- PMID: 3114569
Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells
J R Frey et al. Lymphokine Res. 1987 Summer.
Abstract
Human peripheral blood monocytes and NK cell enriched lymphocytes were purified by counterflow centrifugal elutriation. The cell populations were characterized by surface marker analysis using monoclonal antibodies. A variety of molecules were found to be capable of activating monocytes and NK cells to enhanced tumoricidal activity. Tumoricidal activity was evaluated using a colorimetric microassay. Numbers of tumor cell targets surviving exposure to monocytes or NK cells were calculated by computer analysis of colorimetric data derived by target cell-dependent dye reduction. The results indicated that monocyte effector cells were cytotoxic to the NK sensitive K562 cell line and to the monocyte sensitive TU5 line. Depletion of NK contaminants from the monocyte population by complement mediated cytolysis did not affect the capacity of the monocytes to kill either target. Monocyte mediated cytotoxicity was enhanced by treatment of the monocytes with recombinant IFN-alpha, IFN-beta, or IFN-tau; each in a dose-dependent manner. Simultaneous treatment of monocytes with IFN-alpha and IFN-tau resulted in additive but not synergistic effects. NK cell cytotoxicity was enhanced by treatment with IL-2 or IFN-tau. Enhancement of monocyte and NK cell cytotoxicity by IFN or IL-2 was dependent upon the time in culture of the effector cells, the duration of the effector phase, and the effector to target cell ratio. IFN or IL-2 treatment alone did not reduce target cell viability. The results suggest that monocytes as well as NK cells are capable of providing a natural defence against neoplasia, that monocytes can kill NK targets and NK cells can kill monocyte targets, and that these cytotoxic activities are enhanced by IFN or IL-2.
Similar articles
- Induction by interferon-alpha of tumoricidal activity of adherent mononuclear cells from human blood: monocytes as responder and effector cells.
Sone S, Utsugi T, Shirahama T, Ishii K, Mutsuura S, Ogawara M. Sone S, et al. J Biol Response Mod. 1985 Apr;4(2):134-40. J Biol Response Mod. 1985. PMID: 3998764 - Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z. Reiter Z. Crit Rev Immunol. 1993;13(1):1-34. Crit Rev Immunol. 1993. PMID: 8466640 Review. - Cancer immunotherapy with natural killer cells.
Herberman RB. Herberman RB. Semin Oncol. 2002 Jun;29(3 Suppl 7):27-30. doi: 10.1053/sonc.2002.33079. Semin Oncol. 2002. PMID: 12068385 Review.
Cited by
- Nerve growth factor induces growth and differentiation of human B lymphocytes.
Otten U, Ehrhard P, Peck R. Otten U, et al. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10059-63. doi: 10.1073/pnas.86.24.10059. Proc Natl Acad Sci U S A. 1989. PMID: 2557615 Free PMC article. - Role of interferon gamma and tumour necrosis factor alpha in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line.
van de Loosdrecht AA, Ossenkoppele GJ, Beelen RH, Broekhoven MG, Langenhuijsen MM. van de Loosdrecht AA, et al. Cancer Immunol Immunother. 1992;34(6):393-8. doi: 10.1007/BF01741750. Cancer Immunol Immunother. 1992. PMID: 1563017 Free PMC article. - A cytotoxic effect of human lactoferrin fusion with Fc domain of IgG.
Zaczyńska E, Kocięba M, Artym J, Kochanowska I, Kruzel ML, Zimecki M. Zaczyńska E, et al. Biometals. 2023 Jun;36(3):617-627. doi: 10.1007/s10534-022-00443-z. Epub 2022 Sep 22. Biometals. 2023. PMID: 36136256 - Expression of functional trk protooncogene in human monocytes.
Ehrhard PB, Ganter U, Stalder A, Bauer J, Otten U. Ehrhard PB, et al. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5423-7. doi: 10.1073/pnas.90.12.5423. Proc Natl Acad Sci U S A. 1993. PMID: 8390664 Free PMC article.